On September 9th, 2025, the third session of the highly anticipated "Academic Symposium Series on Autoimmune Diseases in Rheumatology and Immunology" was successfully held online.
Building on the professional standards and academic influence of previous sessions, this meeting once again brought together top domestic and international experts to conduct in-depth discussions on the latest research advancements and clinical challenges in autoimmune diseases.
Having successfully completed three sessions, this series has gradually developed its unique academic characteristics.
We remain committed to establishing a high-quality, sustainable communication platform for the rheumatology and immunology community, driving innovative development in the field.
The conference agenda demonstrated enhanced integration of clinical practice and cutting-edge research.
Professor Ruo-Mei Cui from the First Affiliated Hospital of Kunming Medical University led expert discussions on trending topics including "Tetrazaocloprostone's PSS-GHCS Treatment Paradigm."
The First Affiliated Hospital of China Medical University showcased practical achievements in biologic therapy for PSS through comprehensive clinical data.
Notably, a newly introduced challenging case discussion session provided platforms for scholars at different levels to exchange insights.
Participants actively contributed during panel discussions, sparking lively debates on clinical dilemmas and research challenges that elevated the event to its peak.
Building on the success of previous editions, this conference achieved breakthroughs in both thematic depth and interactive formats.
This series is emerging as a pivotal force driving academic advancement in the field.
